Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
No clinical trials have been registered for amelogenesis imperfecta type 2.
15 publications have been identified in PubMed for amelogenesis imperfecta type 2. Research spans Basic Science / Preclinical (71%), Review / Meta-Analysis (14%), and Epidemiology / Natural History (7%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 10 | 71% |
Research summaries | 2 | 14% |
Disease patterns and progression | 1 | 7% |
New treatment approaches | 1 | 7% |
Wang SK (2026). [PMID: 41585151](https://pubmed.ncbi.nlm.nih.gov/41585151/). *J Dent Sci*. [Basic Science / Preclinical]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:42 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Sriwattanapong K (2026). [PMID: 40693438](https://pubmed.ncbi.nlm.nih.gov/40693438/). *Cell Prolif*. [Basic Science / Preclinical]
Leban T (2026). [PMID: 41385922](https://pubmed.ncbi.nlm.nih.gov/41385922/). *Int Dent J*. [Review / Meta-Analysis]
Zhang Z (2025). [PMID: 39856501](https://pubmed.ncbi.nlm.nih.gov/39856501/). *Beijing Da Xue Xue Bao Yi Xue Ban*. [Basic Science / Preclinical]
Li M (2025). [PMID: 40680053](https://pubmed.ncbi.nlm.nih.gov/40680053/). *PLoS One*. [Basic Science / Preclinical]
Sharmin N (2025). [PMID: 40569950](https://pubmed.ncbi.nlm.nih.gov/40569950/). *PLoS One*. [Basic Science / Preclinical]
Kamps R (2025). [PMID: 40506835](https://pubmed.ncbi.nlm.nih.gov/40506835/). *Mol Genet Genomic Med*. [Gene Therapy / Novel Therapeutics]
Zarinfar M (2025). [PMID: 41294875](https://pubmed.ncbi.nlm.nih.gov/41294875/). *Cells*. [Review / Meta-Analysis]
Yu S (2024). [PMID: 38761453](https://pubmed.ncbi.nlm.nih.gov/38761453/). *Arch Oral Biol*. [Basic Science / Preclinical]
Wang SK (2024). [PMID: 38892321](https://pubmed.ncbi.nlm.nih.gov/38892321/). *Int J Mol Sci*. [Basic Science / Preclinical]